Quick Takeaways
- D. E. SHAW & CO, L.P. filed SCHEDULE 13G for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT).
- Disclosed ownership: 5.1%.
- Date of event: 18 Jul 2025.
D. E. SHAW & CO, L.P. - 18 Jul 2025 SCHEDULE 13G Report for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT)
- Filing Manager
- D. E. SHAW & CO, L.P.
- Reporting Manager
- D. E. Shaw & Co., L.P.
- Symbol
- SRPT
- Shares outstanding
- 99,213,961 shares
- Disclosed Ownership
- 5,059,912 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 25 Jul 2025, 16:08:08 UTC
- Date of event
- 18 Jul 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"D. E. SHAW & CO, L.P. disclosed 5.1% ownership in Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT) on 18 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Jul 2025, 16:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| D. E. Shaw & Co., L.P. | 5.1% | 5,059,912 | 0 | 5,000,212 | /s/ Daniel R. Marcus | Daniel R. Marcus / Chief Compliance Officer | |
| David E. Shaw | 5.1% | 5,059,912 | 0 | 5,000,212 | /s/ Daniel R. Marcus | Daniel R. Marcus / Attorney-in-Fact for David E. Shaw |